Published • loading... • Updated
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments
Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates through a collaboration that could generate up to $510 million in milestone payments for the artificial intelligence-based drug design company whose “lab-in-the-loop” approach combines AI with a continuous feedback loop of experimental wet-lab data. The collaboration, launched through a multi-target discovery collaboration and license agreement, is d…
1 Articles
1 Articles
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments
Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates through a collaboration that could generate up to $510 million in milestone payments for the artificial intelligence-based drug design company whose “lab-in-the-loop” approach combines AI with a continuous feedback loop of experimental wet-lab data. The collaboration, launched through a multi-target discovery collaboration and license agreement, is d…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
